Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Search News Archive

Pipeline Monitor
Expanded US use for Xarelto
While AZ's Lynparza gets fourth orphan nod.
Perspective
The pitfalls of political hype
Surprise! Your new drug is now a miracle cure.
Approvals Action
More generics added
Alphapharm and Boucher & Muir drugs approved.